# A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease

> **NCT02385019** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Instituto de Medicina Molecular João Lobo Antunes** · enrollment: 22 (estimated)

## Conditions studied

- Graft vs Host Disease

## Interventions

- **BIOLOGICAL:** Donor regulatory T cell adoptive immunotherapy in chronic graft versus host disease

## Key facts

- **NCT ID:** NCT02385019
- **Lead sponsor:** Instituto de Medicina Molecular João Lobo Antunes
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2019-03
- **Final completion:** 2019-12
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2018-03-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02385019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02385019, "A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02385019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*